Targeting Inflammation to Reduce Atherosclerotic Cardiovascular Risk in People With HIV Infection

J Am Heart Assoc. 2020 Feb 4;9(3):e014873. doi: 10.1161/JAHA.119.014873. Epub 2020 Jan 24.
No abstract available

Keywords: HIV infection; atherosclerosis; inflammation; prevention.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / therapeutic use*
  • Atherosclerosis / epidemiology
  • Atherosclerosis / immunology
  • Atherosclerosis / prevention & control*
  • Atherosclerosis / virology
  • HIV / immunology
  • HIV Infections / drug therapy*
  • HIV Infections / epidemiology
  • HIV Infections / immunology
  • HIV Infections / virology
  • Heart Disease Risk Factors
  • Host-Pathogen Interactions
  • Humans
  • Inflammation / drug therapy*
  • Inflammation / epidemiology
  • Inflammation / immunology
  • Inflammation / virology
  • Molecular Targeted Therapy
  • Risk Assessment
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents